FTC official: Illumina/PacBio was a “future innovation story”
The US Federal Trade Commission’s deputy director of competition has shed light on her agency’s challenge to the now-abandoned Illumina/Pacific Biosciences deal.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.